However, the difference in OS did not reach statistical significance between the groups.
← all excerpts
Efficacy and safety of poly ADP-ribose polymerase inhibitors (PARPis) in extensive-stage small-cell lung cancer (ES-SCLC) treatment: a systematic review and meta-analysis.
1
—
—